Brontuss

Manufacturer
Portal Inc.
Effective date
2009-12-17
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:23:04

Label at a glance#

ProductBrontuss DX
Active ingredientDextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride
Label structure8 sections

Indications and uses

temporarily relieves these symptoms, due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: cough due to minor throat and bronchial irritation helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive nasal congestion reduces swelling of nasal passages

Dosage and administration

Do not exceed recommended dosage. Adults and Children 12 years of age and older:              2 teaspoonfuls (10mL) every 6 hours, not to exceed 4 doses in a 24 hour period. Children 6 to under 12 years of age: 1 teaspoonful (5 mL) every 6 hours, not to exceed 4 doses in a 24 hour period. Children under 6 years of age: Not recommended for use.

Storage and handling

Store at 59 o -86 o F (15 o -30 o C)

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredients                             Purpose
(in each 5 mL teaspoonful)
Dextromethorphan Hydrobromide 20 mg...... Antitussive
Guaifenesin 200 mg................................ Expectorant
Phenylephrine Hydrochloride 10 mg..........Decongestant

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms, due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
  • cough due to minor throat and bronchial irritation
  • helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive
  • nasal congestion
  • reduces swelling of nasal passages

Warnings

WARNINGS SECTION

Do not exceed recommended dosage.

Do not use this product

OTC - DO NOT USE SECTION

  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • a cough that lasts or is chronic such as occurs with smoking, asthma or emphysema
  • a cough that occurs with too much phlegm (mucus)
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • trouble urinating due to an enlarged prostate gland

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • nervousness, dizziness, or sleeplessness occur
  • cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache. These could be signs of a serious condition.
  • new symptoms occur

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Do not exceed recommended dosage.
Adults and Children 12 years of age and older:             
2 teaspoonfuls (10mL) every 6 hours, not to exceed 4 doses in a 24 hour period.
Children 6 to under 12 years of age:
1 teaspoonful (5 mL) every 6 hours, not to exceed 4 doses in a 24 hour period.
Children under 6 years of age:
Not recommended for use.

Other information

STORAGE AND HANDLING SECTION

Store at 59o-86oF (15o-30oC)

Inactive ingredients

INACTIVE INGREDIENT SECTION

cherry flavor, citric acid, maltitol, propylene glycol, purified water, sodium citrate, sodium saccharin, and sorbitol.

Questions? Comments?

OTC - QUESTIONS SECTION

Serious side effects associated with this product may be reported to this number.
Call (787)832-6645
Operation Hours: Monday - Friday, 8 A.M. to 4 P.M. Atlantic Standard Time (AST)
portalpharmaceutical@gmail.com

Manufactured for:

Portal Pharmaceutical
Mayaguez, PR 00680

Rev. 10/09

PRODUCT PACKAGING:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

The packaging below represents the labeling currently used:

Principal Display Panel and Side Panel for 118mL Label:

NDC 49963-913-04

Brontuss
DX

Antitussive / Expectorant
Decongestant

Each teaspoonful (5 mL) for oral administration contains:
Dextromethorphan HBr.............. 20 mg
Guaifenesin.............................200 mg
Phenylephrine HCl.................... 10 mg


Dye Free - Sugar Free

Alcohol Free - Gluten Free

4 oz. (118 mL)

Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.

Supplied in a tight, light-resistant container with a child-resistant cap.

Manufactured for:
Portal Pharmaceutical
Mayaguez, PR 00680

Rev. 10/09

Principal Display Panel and Side Panel for 15 mL Label:

NDC 49963-913-15

Brontuss
DX

Antitussive / Expectorant
Decongestant

Each teaspoonful (5 mL) for oral administration contains:
Dextromethorphan HBr.......... 20 mg
Guaifenesin........................ 200 mg
Phenylephrine HCl................ 10 mg

Dye Free / Sugar Free
Alcohol Free / Gluten Free

15 mL (1/2 fl oz)

Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.
Supplied in a tight, light-resistant container with a child-resistant cap.

Professional Sample:

Not For Sale

Manufactured for:
Portal Pharmaceutical
Mayaguez, PR 00680

Rev. 10/09

Brontuss DX Packaging
Brontuss DX Packaging

Brontuss DX Packaging
Brontuss DX Packaging

Brontuss DX Packaging
Brontuss DX Packaging

Brontuss DX Packaging
Brontuss DX Packaging

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1039286dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 5 mL Oral SolutionPSN2
1039286dextromethorphan hydrobromide 4 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral SolutionSCD2
1039286dextromethorphan HBr 20 MG / guaifenesin 200 MG / phenylephrine HCl 10 MG per 5 ML Oral SolutionSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DEXTROMETHORPHAN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
GUAIFENESIN Pharmacologic Class Indexing1Indexing - Pharmacologic Class20211129
PHENYLEPHRINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4fe95224-f543-4dbb-9445-8cca122b48c8Product name120150609
e8718272-64cb-4436-969b-176c3067c8f4Product name120150609
106ff02a-57e1-4c4c-a307-fd582ff4e311Product name120150212

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49963-913-042019-10-21C16284748780-1956f9ecf-da1f-621f-e053-dbdaa90a74adBrontuss DX
49963-913-152019-10-21C16284748780-1956f9ecf-da1f-621f-e053-dbdaa90a74adBrontuss DX

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49963-913-04BrontussDX118 mL in 1 BOTTLELIQUID1182
49963-913-15BrontussDX15 mL in 1 BOTTLELIQUID152

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49963-913BRONTUSS DX (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE) LIQUID [PORTAL INC.]2Legacy NDC, 2 package rows20091221_c83c41c1-e66f-4aea-82ad-2028dbf50f95.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
49963-913-04ML - Milliliter49963-913c81fa09c-c0db-43de-b438-82317d38c56412012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Dextromethorphan HydrobromideACTIVE INGREDIENT9D2RTI9KYH2
GuaifenesinACTIVE INGREDIENT495W7451VQ2
Phenylephrine HydrochlorideACTIVE INGREDIENT04JA59TNSJ2
DextromethorphanACTIVE MOIETY7355X3ROTS2
GuaifenesinACTIVE MOIETY495W7451VQ2
PhenylephrineACTIVE MOIETY1WS297W6MV2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49963-91349963-913-04, 49963-913-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
5012801b-7bba-48d0-8636-68300642c6bdc83c41c1-e66f-4aea-82ad-2028dbf50f952009-12-17WarningsExact identifier
spl id: 5012801b-7bba-48d0-8636-68300642c6bd
spl set id: c83c41c1-e66f-4aea-82ad-2028dbf50f95

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.